Multiple Sclerosis – Challenges in Diagnosis
Total Views: 124 | Total Downloads: 88
Keywords:multiple sclerosis, numbness, challenge, diagnosis, non-specific
Multiple Sclerosis is an inflammatory demyelinating disease that affects the central nervous system, and is uncommon among the Asian population. It can present with a variety of symptoms, depending on the location of the demyelinating plaques, which could also potentially mimic a range of neurological and non-neurological disorders. We report a 24-year-old woman who presented with recurrent non-specific lower limb numbness, without any other neurological symptoms or signs. The symptoms were presumed to be nonspecific, but they re-occurred eight months later, leading to a more extensive investigation, including whole spine and brain MRI. The MRI showed multiple white matter lesions that are hyperintense on T2W/FLAIR, seen at the right corona radiata, bilateral parietal lobes, right periventricular region and spinal cord, with a simultaneous presence of gadolinium-enhancing and nonenhancing lesions, fulfilling 2017 Mc Donald’s diagnostic criteria for multiple sclerosis. After the careful exclusion of differential diagnoses, she was given pulsed IV methylprednisolone for 5 days, followed by oral teriflunomide. She improved partially, and at 2 months following discharge, she was tolerating the medication well with no further relapses.
Filippi, M., & Bar-Or, A. (2018). Piehl Fet al. Multiple sclerosis. Nat Rev Dis Primers, 4(1), 43.
Rosati, G. (2001). The prevalence of multiple sclerosis in the world: an update. Neurological sciences, 22(2), 117-139. doi.org/10.1007/s100720170011
Viswanathan, S., Rose, N., Masita, A., Dhaliwal, J. S., Puvanarajah, S. D., Rafia, M. H., & Muda, S. (2013). Multiple sclerosis in Malaysia: demographics, clinical features, and neuroimaging characteristics. Multiple sclerosis international, 2013. doi.org/10.1155/2013/614716
Thompson, A. J., Banwell, B. L., Barkhof, F., Carroll, W. M., Coetzee, T., Comi, G., ... & Cohen, J. A. (2018). Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology, 17(2), 162-173. doi.org/10.1016/S1474-4422(17)30470-2
Rae-Grant, A. D., Eckert, N. J., Bartz, S., & Reed, J. F. (1999). Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity. Multiple Sclerosis Journal, 5(3), 179-183. doi.org/10.1177/135245859900500307
Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017). Diagnosis of multiple sclerosis: progress and challenges. The Lancet, 389(10076), 1336-1346. doi.org/10.1016/S0140-6736(16)30959-X
Traboulsee, A., Simon, J.H., Stone, L., Fisher, E., Jones, D.E., Malhotra, A., Newsome, S.D., Oh, J., Reich, D.S., Richert, N. and Rammohan, K. (2016). Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. American Journal of Neuroradiology, 37(3), 394-401. doi.org/10.3174/ajnr.A4539
Rovira, À., Wattjes, M.P., Tintoré, M., Tur, C., Yousry, T.A., Sormani, M.P., De Stefano, N., Filippi, M., Auger, C., Rocca, M.A. and Barkhof, F. (2015). MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process. Nature Reviews Neurology, 11(8), 471-482. doi.org/10.1038/nrneurol.2015.106
onfavreux, C., O'Connor, P., Comi, G., Freedman, M.S., Miller, A.E., Olsson, T.P., Wolinsky, J.S., Bagulho, T., Delhay, J.L., Dukovic, D. and Truffinet, P. (2014). Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Neurology, 13(3), 247-256. doi.org/10.1016/S1474-4422(13)70308-9
O'Connor, P., Wolinsky, J.S., Confavreux, C., Comi, G., Kappos, L., Olsson, T.P., Benzerdjeb, H., Truffinet, P., Wang, L., Miller, A. and Freedman, M.S. (2011). Randomized trial of oral teriflunomide for relapsing multiple sclerosis. New England Journal of Medicine, 365(14), 1293-1303. doi.org/10.1056/NEJMoa1014656
How to Cite
Copyright (c) 2022 Nur Ezzaty Mohammad Kazmin, Hui Jan Tan, Hana Maizuliana Solehan, Fatimah Zanirah, Wei Ming Tan, M Firdaus A Bakar, Sarah Zulaikha Samad
This work is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of this article will be vested to author(s) and granted the journal right of first publication with the work simultaneously licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated.